There are several case reports describing a temporal correlation between the first clinical
manifestation of multiple sclerosis (MS) and the occurrence of relapses with vaccination …

Objective: To describe a temporal association between COVID-19 vaccine administration
and multiple sclerosis (MS) relapses. Methods: This case series study was collected in four …

Vaccination against SARS-CoV-2 is critical to control the pandemic. Although there are not
yet sufficient data regarding the COVID-19 risk of patients with multiple sclerosis (MS), it is …

We describe a case of acute relapse in a woman with Multiple Sclerosis (MS) shortly after
the mRNA COVID-19 vaccination. The patient received a diagnosis of MS in November …

Introduction mRNA coronavirus disease 2019 (COVID-19) vaccination has been widely
used to arrest the spread of the severe acute respiratory syndrome coronavirus 2 (SARS …

Background Multiple sclerosis (MS) with onset in the setting of acute SARS-CoV-2 virus
infection has been reported, and reactivation of MS following non-mRNA COVID-19 …

Vaccine administration may be involved in the development of some central nervous system
demyelinating diseases. The COVID-19 vaccine is being administered to the entire …

Multiple sclerosis (MS) is an auto-immune mediated neurological disorder that affects the
central nervous system and leads to myelin sheath destruction. The pathogenesis of MS …

Mass vaccination against coronavirus disease 19 (COVID-19) has effectively controlled the
pandemic and has been remarkably effective and safe. Reports of a few adverse events …

Discussion Sufficient data have been available to assure the safety of vaccination against
various diseases in MS patients [3, 4]. Now, facing an unexpected devastating pandemic …